Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1998-02-10
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549283, 549285, 549287, 549289, 514261, 544277, C07D31112, C07D31114, C07D31116, A61K 3137
Patent
active
057169829
ABSTRACT:
New retinoid compounds, as coumarin retinoids and/or purine retinoids and compositions thereof, are provided which exhibit therapeutic and/or biological activity on cancer or precancer cells, as well as to methods of use of same.
REFERENCES:
patent: 3541097 (1970-11-01), Beyerle et al.
patent: 4126693 (1978-11-01), Gander et al.
patent: 4144336 (1979-03-01), Boltze et al.
patent: 4151179 (1979-04-01), Appleton et al.
patent: 4190594 (1980-02-01), Gander et al.
patent: 4310546 (1982-01-01), Gander
patent: 4323581 (1982-04-01), Gander
patent: 4385175 (1983-05-01), Just et al.
patent: 4523042 (1985-06-01), Loev et al.
patent: 4602034 (1986-07-01), Briet et al.
patent: 4713465 (1987-12-01), Kramer et al.
patent: 4783533 (1988-11-01), Briet et al.
patent: 4960908 (1990-10-01), Ito et al.
patent: 5096713 (1992-03-01), Philippe et al.
patent: 5096924 (1992-03-01), Ishizuka et al.
patent: 5116954 (1992-05-01), Briet et al.
patent: 5124083 (1992-06-01), Shealy
patent: 5141746 (1992-08-01), Fleury et al.
Shiping Xu et al., CA 96:123037, 1982.
Shiping Xu et al., Yaoxue Xerbao (1981), 16(9), 678-86.
S. Shibata, Anti-tumorgenic chalcones, Stem Cells, vol. 12:44-62, 1994.
Srivastava et al. Effect of quercetin on serine/threonine and tyrosine protein kinase, Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological and Structure-Activity Relationships, pp. 315-318, 1986.
Piantelli et al. Type II Estrogen Binding Sites and Antiproliferative Activity of Quercetin in Human Meningiomas, Cancer, vol. 71:193-199, 1993.
B. Havsteen, Flavonoids, A Class of Natural Products of High Pharmacological Potency, Biochemical Pharmacology, vol. 32:1141-1148, 1983.
Chae et al. Effects of synthetic and naturally occurring flavonoids on with cytochrome P-450 inducers, Cancer Letters, vol. 60, pp. 15-24, 1991.
M.E. Marshall et al. Growth-inhibitory effects of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitro, J. Cancer Res. & Clin. Oncol., vol. 120, pp. S3-S10, 1994.
Bibby et al. Flavone acetic acid-from laboratory to clinic and back, Anti-Cancer Drugs, vol. 4, pp. 3-17, 1993.
Jing et al. Structural Requirements for Differentiation-Induction and Growth-Inhibition of Mouse Erythroleukemia Cells by Isoflavones, Anticancer Research, vol. 15, pp. 1147-1152, 1995.
Blazsek et al., Retinoic acid in mono-or combined differentiation therapy of myelodysplasia and acute promyelocytic leukemia, Biomed & Pharmacother, vol. 45, pp. 169-177, 1991.
Abstract--Cassady et al., Recent Advances in the Discovery of Potential Cancer Chemopreventive Agents, Abstract Collection of International Symposium on Recent Advances in Chemistry and Molecular Biology of Cancer Research, Beijing, China, pp. 5-6, 1991.
Castaigne et al., All-Trans Retinoic Acid as a Differentiation Therapy for Acute Promyelocytic Leukemia. I. Clinical Results, Blood, vol. 76, No. 9, pp. 1704-1709, 1 Nov. 1990.
Chomienne et al., All-Trans Retinoic Acid in Acute Promyelocytic Leukemias. II. In Vitro Studies: Structure-Function Relationship, Blood, vol. 76, No. 9, pp. 1710-1717, 1 Nov. 1990.
Chomienne et al., Structure-Activity Relationships of Aromatic Retinoids on the Differentiation of the Human Histiocytic Lymphoma Cell Line U-937, Leukemia Research, vol. 10, No. 11, pp.1301-1305, 1986.
Clarkson, Retinoic Acid in Acute Promyelocytic Leukemia: The Promise and the Paradox, Cancer Cells, vol. 3, No. 6, pp. 211-220, Jun. 1991.
Dawson et al., Aromatic Retinoic Acid Analogues. Synthesis and Pharmacological Activity, Journal of Medicinal Chemistry, vol. 24, No. 5, pp. 583-592, 1981.
Dawson et al., Conformationally Restricted Retinoids, J. Med. Chem., vol. 27, No. 11, pp. 1516-1531, 1984.
Degos, All-trans retinoic acid (ATRA) therapeutical effect in acute promyelocytic leukemia, Biomed & Pharmacother, vol. 46, pp. 201-209, 1992.
Abstract--Du et al., Comparison of Toxicities of 4-(ethoxycarbophenyl) Retinamide and Some Other Retinoids, Institute of Materia Medica, vol. 18, No. 5, 1982.
Edwards et al., Chalcones: A New Class of Antimitotic Agents, J. Med. Chem., vol. 33, pp. 1948-1954, 1990.
Egan et al., The Pharmacology, Metabolism, Analysis, and Applications of Coumarin and Coumarin-Related Compounds, Drug Metabolism Reviews, vol. 22, No. 5, pp. 503-529, 1990.
Abstract--Han et al., Effects of S86019, An Active Component From Puralia Lobata, On Cell Differentiation and Cell Cycle Traverse of HL-60 Cells, Chinese Journal of Cancer Research, vol. 2, No. 3, pp. 51-53, 1990.
Han et al., Evaluation of N-4-(Hydroxycarbophenyl) Retinamide as a Cancer Prevention Agent and as a Cancer Chemotherapeutic Agent, In Vivo, vol. 4, pp. 153-160, 1990.
Harvey et al., A New Coumarin Synthesis and Its Utilization for the Synthesis of Polycyclic Compounds with Anticarcinogenic Properties, J. Org. Chem., vol. 53, No. 17, pp. 3936-3943, 1988.
Harvey et al., A New Chromone and Flavone Synthesis and Its Utilization for the Synthesis of Potentially Antitumorigenic Polycyclic Chromones and Flavones, J. Org. Chem., vol. 55, No. 25, pp. 6161-6166, 1990.
Abstract--Ho et al., Synthesis and Structure--Activity Relationship of of International Symposium on Recent Advances in Chemistry and Molecular Biology of Cancer Research, Beijing, China, pp. 68-69, Jul. 1991.
Abstract--Jing et al., Differentiation of B16 Melanoma Cells Induced by Daidzein, Chinese Journal of Pharmacology and Toxicology, vol. 6, No. 4, pp. 278-280, Nov. 1992.
Kizaki et al., Differentiation-Inducing Agents in the Treatment of Myelodysplastic Syndromes, Seminars in Oncology, vol. 19, No. 1, pp. 95-105, Feb. 1992.
Kagechika et al., Retinobenzioc Acids. 3. Structure-Activity Relationships of Retinoidal Azobenzene-4-carboxylic Acids and Stilbene-4-carboxylic Acids, J. Med. Chem., vol. 32, pp.1098-1108, 1989.
LoCoco et al., Molecular Evaluation of Response to All-Trans-Retinoic Acid Therapy in Patients With Acute Promyelocytic Leukemia, Blood, vol. 77, No. 8, pp. 1657-1659, 15 Apr. 1991.
Middleton, Jr., Effects of Flavonoids on Immune and Inflammatory Cell Functions, Biochemcial Pharmacology, vol. 43, No. 6, pp. 1167-1179, 1992.
Nair et al., Novel Coumarins as Potential Anticarcinogenic Agents, Carcinogenesis, vol. 12, No. 1, pp. 65-69, 1991.
Newton et al., Structure-Activity Relationships of Retinoids in Hamster Tracheal Organ Culture, Cancer Research, vol. 40, pp. 3413-3425, Oct. 1980.
Preuss-Ueberschar et al., Drug Res., vol. 34, pp. 1305-1313, 1984.
Sato et al., Functional Studies of Newly Synthesized Benzoic Acid Derivatives: Identification of Highly Potent Retinoid-Like Activity, Journal of Cellular Physiology, vol. 135, pp. 179-188, 1988.
Shealy et al., Terminal Bifunctional Retinoids. Synthesis and Evaluation Related to Cancer Chemopreventive Activity, J. Med. Chem., vol. 31, pp. 1124-1130, 1988.
Skrede et al., Retinyl Esters in Chylomicron Remnants Inhibit Growth of Myeloid and Lymphoid Leukaemic Cells, European Journal of Clinical Investigation, vol. 21, pp. 574-579, 1991.
Smith et al., Retinoids in Cancer Therapy, Journal of Clinical Oncology, vol. 10, vo. 5, pp. 839-864, May 1992.
Abstract--Song et al., Differentiation of Human Promyelocytic Leukemia (HL-60) Cells Induced By New Synthetic Retinoids 4-(ethoxycarbophenyl) Retinamide and 4-(hydroxycarbophenyl) Retinamide, Institute of Materia Medica, Chinese Academy of Medical Sciences, pp. 576-581, 1984.
Warrell, Jr., All-Trans-Retinoic Acid: What Is It Good For? Journal of Clinical Oncology, vol. 10, No. 11, pp. 1659-1661, Nov. 1992.
Han Rui
Xu Shi-Ping
Institute of Materia Medica, an institute of the Chinese Academy
Richter Johann
Stockton Laura L.
LandOfFree
Retinoids and methods of use of same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retinoids and methods of use of same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retinoids and methods of use of same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2077730